1143 PHASE IIA TRIAL OF ENCAPSULATED RAPAMYCIN (ERAPA) IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS TO REDUCE INTESTINAL POLYP BURDEN: 6 MONTH INTERIM RESULTS Gastroenteology Leggi → Maggio 2024
Sa1567 METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) – HOW COMMON IS IT? Gastroenteology Leggi → Maggio 2024
Sa1811 IT'S TIME TO INCLUDE CAPSULE ENDOSCOPY TO ASSESS MUCOSAL ACTIVITY AS PART OF THE 'TREAT-TO-TARGET’ STRATEGY IN CROHN'S DISEASE: A REAL-LIFE EXPERIENCE FROM A REFERENCE CENTER IN ARGENTINA. Gastroenteology Leggi → Maggio 2024
Sa1763 RELIABILITY OF SONOGRAPHIC PARAMETERS IS KEY IN THE DEVELOPMENT OF A VALID AND RESPONSIVE ACTIVITY INDEX IN CROHN'S DISEASE (THE USE-IT STUDY) Gastroenteology Leggi → Maggio 2024
Sa1463 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) REDUCE SEVERITY AND LENGTH OF STAY IN PATIENTS WITH ACUTE PANCREATITIS (AP): A SYSTEMATIC REVIEW AND META-ANALYSIS Gastroenteology Leggi → Maggio 2024
303 GREEN ENDOSCOPY INITIATIVE: AN EFFORT TO REDUCE ENDOSCOPIC WASTE DURING COLONOSCOPIES IN A LARGE TERTIARY CARE INSTITUTE Gastroenteology Leggi → Maggio 2024
Su1612 ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES? Gastroenteology Leggi → Maggio 2024
Mo1856 INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB SWITCH MAY REDUCE THE RISK OF IMMUNOGENICITY RELATED TREATMENT FAILURE AND CAN BE USED TO FACILITATE IMMUNOMODULATOR WITHDRAWAL Gastroenteology Leggi → Maggio 2024
Mo1545 READINESS TO REDUCE UNHEALTHY ALCOHOL USE IN HEPATOLOGY CLINICS SERVING VULNERABLE PATIENTS WITH CHRONIC LIVER DISEASE: A COMPARISON BETWEEN TWO INTEGRATED HEALTH CARE SYSTEMS Gastroenteology Leggi → Maggio 2024
Mo1536 ENDOGENOUS ENRICHMENT IN OMEGA 3 FATTY ACIDS ATTENUATED LIVER INJURY CAUSED BY CHRONIC ETHANOL CONSUMPTION AND SARS-COV-2 INFECTION IN MICE Gastroenteology Leggi → Maggio 2024
Su1608 SEPSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES AND HIGHER MORTALITY? Gastroenteology Leggi → Maggio 2024
354 LARGE CALIBER ENDOSCOPIC BALLOON DILATION IN PATIENTS WITH PERSISTENT DYSPHAGIA AFTER MAGNETIC SPHINCTER AUGMENTATION (MSA) IS SAFE AND MAY REDUCE THE NEED FOR SUBSEQUENT DILATIONS AND DEVICE REMOVAL Gastroenteology Leggi → Maggio 2024
73 METASTASECTOMY FOR STAGE IV COLORECTAL CANCER IS ASSOCIATED WITH IMPROVED SURVIVAL – BUT NOT ALL PATIENTS HAVE ACCESS TO IT Gastroenteology Leggi → Maggio 2024
Tu1425 OPEN PANCREATICODUODENECTOMY IN PANCREATIC CANCER: IS IT ASSOCIATED WITH WORSE OUTCOMES IN THE ELDERLY? Gastroenteology Leggi → Maggio 2024
1124 SAVE THE SPLEEN OR FIX IT IN FORMALIN: IS THERE A DIFFERENCE IN PERIOPERATIVE OUTCOME? Gastroenteology Leggi → Maggio 2024
Mo1806 ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE? Gastroenteology Leggi → Maggio 2024